Independent Advisor Alliance Eli Lilly & CO Transaction History

Independent Advisor Alliance

  • $2.74 Billion
  • Q1 2024

A detailed history of Independent Advisor Alliance transactions in Eli Lilly & CO stock. As of the latest transaction made, Independent Advisor Alliance holds 32,804 shares of LLY stock, worth $29.5 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
32,804
Previous 32,269 1.66%
Holding current value
$29.5 Million
Previous $18.8 Million 35.67%
% of portfolio
0.93%
Previous 0.68%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$592.2 - $792.28 $316,827 - $423,869
535 Added 1.66%
32,804 $25.5 Million
Q4 2023

Feb 08, 2024
BUY
$525.19 - $619.13 $285,703 - $336,806
544 Added 1.71%
32,269 $18.8 Million
Q3 2023

Oct 24, 2023
BUY
$434.7 - $599.3 $694,215 - $957,082
1,597 Added 5.3%
31,725 $17 Million
Q2 2023

Jul 28, 2023
BUY
$350.74 - $468.98 $614,496 - $821,652
1,752 Added 6.17%
30,128 $14.1 Million
Q1 2023

May 12, 2023
SELL
$310.63 - $364.82 $210,917 - $247,712
-679 Reduced 2.34%
28,376 $9.74 Million
Q4 2022

Feb 13, 2023
BUY
$321.55 - $374.67 $40,193 - $46,833
125 Added 0.43%
29,055 $10.6 Million
Q3 2022

Nov 04, 2022
SELL
$296.48 - $337.87 $2.17 Million - $2.48 Million
-7,333 Reduced 20.22%
28,930 $9.36 Million
Q2 2022

Aug 04, 2022
SELL
$278.73 - $327.27 $78,880 - $92,617
-283 Reduced 0.77%
36,263 $11.8 Million
Q1 2022

May 06, 2022
BUY
$234.69 - $291.66 $836,435 - $1.04 Million
3,564 Added 10.81%
36,546 $10.5 Million
Q4 2021

Feb 11, 2022
BUY
$224.85 - $279.04 $184,601 - $229,091
821 Added 2.55%
32,982 $9.11 Million
Q3 2021

Nov 01, 2021
BUY
$221.6 - $272.71 $99,055 - $121,901
447 Added 1.41%
32,161 $7.43 Million
Q2 2021

Aug 12, 2021
SELL
$180.55 - $233.54 $545,261 - $705,290
-3,020 Reduced 8.69%
31,714 $7.28 Million
Q1 2021

May 14, 2021
BUY
$164.32 - $212.72 $850,356 - $1.1 Million
5,175 Added 17.51%
34,734 $6.49 Million
Q4 2020

Feb 11, 2021
BUY
$130.46 - $172.63 $6,131 - $8,113
47 Added 0.16%
29,559 $4.99 Million
Q3 2020

Nov 04, 2020
SELL
$146.22 - $169.13 $346,541 - $400,838
-2,370 Reduced 7.43%
29,512 $4.37 Million
Q2 2020

Aug 06, 2020
SELL
$136.42 - $164.18 $469,966 - $565,600
-3,445 Reduced 9.75%
31,882 $5.21 Million
Q1 2020

May 14, 2020
BUY
$119.05 - $147.35 $825,135 - $1.02 Million
6,931 Added 24.41%
35,327 $4.9 Million
Q4 2019

Feb 07, 2020
SELL
$106.92 - $132.43 $50,038 - $61,977
-468 Reduced 1.62%
28,396 $3.73 Million
Q3 2019

Nov 12, 2019
BUY
$106.79 - $116.16 $7,154 - $7,782
67 Added 0.23%
28,864 $3.23 Million
Q2 2019

Aug 12, 2019
SELL
$110.79 - $129.32 $28,029 - $32,717
-253 Reduced 0.87%
28,797 $3.19 Million
Q1 2019

May 07, 2019
BUY
$111.31 - $131.02 $223,955 - $263,612
2,012 Added 7.44%
29,050 $3.77 Million
Q4 2018

Feb 12, 2019
BUY
$105.9 - $118.64 $61,316 - $68,692
579 Added 2.19%
27,038 $3.13 Million
Q3 2018

Nov 13, 2018
BUY
$85.86 - $107.31 $209,240 - $261,514
2,437 Added 10.14%
26,459 $2.84 Million
Q2 2018

Aug 08, 2018
SELL
$75.7 - $86.88 $12,263 - $14,074
-162 Reduced 0.67%
24,022 $2.04 Million
Q1 2018

May 15, 2018
BUY
$74.21 - $87.6 $371 - $438
5 Added 0.02%
24,184 $1.83 Million
Q4 2017

Feb 14, 2018
SELL
$81.94 - $87.89 $3,851 - $4,130
-47 Reduced 0.19%
24,179 $2.08 Million
Q3 2017

Nov 15, 2017
BUY
$77.07 - $85.54 $180,035 - $199,821
2,336 Added 10.67%
24,226 $2.11 Million
Q2 2017

Aug 14, 2017
BUY
N/A
21,890
21,890 $1.8 Million

Others Institutions Holding LLY

# of Institutions
3,722
Shares Held
738M
Call Options Held
7.09M
Put Options Held
7.24M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $853B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Independent Advisor Alliance Portfolio

Follow Independent Advisor Alliance and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email